Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $2.3B |
| Sales growthchange from the year before | +8.1% |
| Gross marginshare of sales left after the direct cost of what it sells | 35.2% |
| Operating marginshare of sales left after running the business | 27.3% |
| Net marginshare of sales kept as profit | 31.1% |
| Free-cash-flow marginspare cash generated per $100 of sales | 25.5% |
| Return on invested capitalprofit made on each $100 put into the business | 20.2% |
| Return on equityprofit vs. shareholders' accounting value | 29.2% |
| Debt / equitydebt vs. shareholders' accounting value | 0.00 |
| Change in share countnegative = the company is buying back its shares | -3.5% |
5 insiders sold $8.1M on the open market.
| Mccarthy KathrynDirector | SoldAug 3 | 10,000 shat $103.53 · $1.0M |
| Guarino CarlDirector | SoldJul 28 | 10,000 shat $103.19 · $1.0M |
| Peterson MichaelExecutive Vice President | SoldJul 28 | 25,000 shat $102.05 · $2.6M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy